N-omega-nitro-L-arginine methyl ester

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
N-omega-nitro-L-arginine methyl ester
Accession Number
DB12750
Description

L-NAME has been investigated for the treatment of Hypotension and Spinal Cord Injury.

Type
Small Molecule
Groups
Investigational
Structure
Thumb
Weight
Average: 233.228
Monoisotopic: 233.112403983
Chemical Formula
C7H15N5O4
Synonyms
  • L-NAME
  • N-nitro-arginine methyl ester
  • NG-nitro-L-arginine methyl ester
  • NG-Nitroarginine methyl ester

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as arginine and derivatives. These are compounds containing arginine or a derivative thereof resulting from reaction of arginine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Arginine and derivatives
Alternative Parents
Alpha amino acid esters / Nitroguanidines / Fatty acid esters / Nitramines / Methyl esters / Monocarboxylic acids and derivatives / Carboximidamides / Organopnictogen compounds / Organic zwitterions / Organic oxides
show 4 more
Substituents
Aliphatic acyclic compound / Allyl-type 1,3-dipolar organic compound / Alpha-amino acid ester / Amine / Arginine or derivatives / Carbonyl group / Carboximidamide / Carboxylic acid ester / Fatty acid ester / Fatty acyl
show 18 more
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
alpha-amino acid ester, L-arginine derivative (CHEBI:7549)

Chemical Identifiers

UNII
V55S2QJN2X
CAS number
50903-99-6
InChI Key
KCWZGJVSDFYRIX-YFKPBYRVSA-N
InChI
InChI=1S/C7H15N5O4/c1-16-6(13)5(8)3-2-4-10-7(9)11-12(14)15/h5H,2-4,8H2,1H3,(H3,9,10,11)/t5-/m0/s1
IUPAC Name
methyl (2S)-2-amino-5-(N'-nitrocarbamimidamido)pentanoate
SMILES
COC(=O)[[email protected]@H](N)CCCNC(=N)N[N+]([O-])=O

References

General References
Not Available
KEGG Compound
C04337
PubChem Compound
39836
PubChem Substance
347828939
ChemSpider
36427
BindingDB
50098937
ChEBI
7549
ChEMBL
CHEMBL7890
ZINC
ZINC000015987659

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2CompletedTreatmentOrthostatic Hypotension / Spinal Cord Injuries (SCI)1
1CompletedBasic ScienceCardiovascular Heart Disease / Cardiovascular Risk / Vasoconstriction1
1RecruitingBasic ScienceCardiovascular Heart Disease / Cardiovascular Risk / Vasoconstriction2
Not AvailableCompletedBasic ScienceCardiovascular Heart Disease1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.698 mg/mLALOGPS
logP-0.76ALOGPS
logP-1.2ChemAxon
logS-2.5ALOGPS
pKa (Strongest Acidic)10.95ChemAxon
pKa (Strongest Basic)8.03ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area143.37 Å2ChemAxon
Rotatable Bond Count7ChemAxon
Refractivity64.67 m3·mol-1ChemAxon
Polarizability22.35 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on October 20, 2016 18:01 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates